These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 23778763
21. Chromogranin A cell density in the rectum of patients with irritable bowel syndrome. El-Salhy M, Mazzawi T, Gundersen D, Hausken T. Mol Med Rep; 2012 Dec; 6(6):1223-5. PubMed ID: 22992886 [Abstract] [Full Text] [Related]
24. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Martínez C, Lobo B, Pigrau M, Ramos L, González-Castro AM, Alonso C, Guilarte M, Guilá M, de Torres I, Azpiroz F, Santos J, Vicario M. Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702 [Abstract] [Full Text] [Related]
25. Serotonin transporter promoter variant: Analysis in Indian IBS patients and control population. Sikander A, Rana SV, Sinha SK, Prasad KK, Arora SK, Sharma SK, Singh K. J Clin Gastroenterol; 2009 Aug; 43(10):957-61. PubMed ID: 19687750 [Abstract] [Full Text] [Related]
26. Effect of Lactobacillus rhamnosus GG supernatant on serotonin transporter expression in rats with post-infectious irritable bowel syndrome. Cao YN, Feng LJ, Liu YY, Jiang K, Zhang MJ, Gu YX, Wang BM, Gao J, Wang ZL, Wang YM. World J Gastroenterol; 2018 Jan 21; 24(3):338-350. PubMed ID: 29391756 [Abstract] [Full Text] [Related]
30. [Role of serotonin in the pathophysiology of the irritable bowel syndrome]. Moskwa A, Boznańska P. Wiad Lek; 2007 Jan 21; 60(7-8):371-6. PubMed ID: 18175558 [Abstract] [Full Text] [Related]
33. Mucosal Serotonin Reuptake Transporter Expression in Irritable Bowel Syndrome Is Modulated by Gut Microbiota Via Mast Cell-Prostaglandin E2. Gao J, Xiong T, Grabauskas G, Owyang C. Gastroenterology; 2022 Jun 21; 162(7):1962-1974.e6. PubMed ID: 35167867 [Abstract] [Full Text] [Related]
34. Lower gastrointestinal disorders in patients with irritable bowel syndrome. Jurcić D, Bilić A, Schwarz D, Luetic K, Marusić M, Vcev A, Gabrić M, Spoljarić L. Coll Antropol; 2008 Sep 21; 32(3):755-9. PubMed ID: 18982748 [Abstract] [Full Text] [Related]
35. Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea. Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, Yoon BC, Choi HS, Sim J, Jang KS. Scand J Gastroenterol; 2014 Jan 21; 49(1):43-51. PubMed ID: 24256141 [Abstract] [Full Text] [Related]
37. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK, Cho SW. J Gastroenterol Hepatol; 2008 Nov 21; 23(11):1689-94. PubMed ID: 19120860 [Abstract] [Full Text] [Related]
38. Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron. Bellini M, Rappelli L, Blandizzi C, Costa F, Stasi C, Colucci R, Giannaccini G, Marazziti D, Betti L, Baroni S, Mumolo MG, Marchi S, Del Tacca M. Am J Gastroenterol; 2003 Dec 21; 98(12):2705-11. PubMed ID: 14687821 [Abstract] [Full Text] [Related]
39. Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome. El-Salhy M, Gilja OH, Hausken T. Mol Med Rep; 2014 Oct 21; 10(4):1753-7. PubMed ID: 25109259 [Abstract] [Full Text] [Related]